Clinical trial Recruiting at 1 site Observational Ages 18 to 45 Women only

Reframing how the uterus works in heavy menstrual bleeding

Official title: Reframing Endometrial Physiology by Advanced Integrated Research

Run by University Hospital Southampton NHS Foundation Trust · NCT07557992 · Data updated 2026-11-12

This project will try wearable sensors, MRI scans, and blood/tissue samples to find measurable uterine changes linked to heavy menstrual bleeding in people aged 18–45 with and without heavy periods.

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexWomen only
Enrollment100 (estimated)
SponsorUniversity Hospital Southampton NHS Foundation Trust
Academic / other
Locations1 site (Southampton)
StatusRecruiting
StartedFebruary 6, 2026
Main results expectedFebruary 1, 2029
Study endsFebruary 1, 2030
Registry record updatedApril 30, 2026
Trial IDNCT07557992 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 18–45 who have menstrual periods, with or without heavy bleeding, who are not pregnant or breastfeeding and who have not used hormonal treatments in the past two months.

Probably not a fit

People who are pregnant or breastfeeding, have known uterine malignancy, severe anemia requiring urgent treatment, acute gynecological emergencies, cannot undergo MRI, or cannot provide informed consent are excluded and would not benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will enroll about 130 participants with and without heavy menstrual bleeding and collect wearable electrophysiology data during menses, pelvic MRI scans, and biosamples. Objective measures of blood loss will be combined with device recordings and imaging to identify physiological signatures of heavy bleeding. Data from two sites will be integrated to look for reproducible patterns in uterine contractility, endometrial repair, and tissue composition. The goal is to generate candidate biomarkers that could support scalable, non-invasive diagnostics.

Why it matters

Potential benefit: If successful, this work could lead to non-invasive tests using wearables or imaging to diagnose causes of heavy menstrual bleeding and help guide treatment choices.

How similar studies have gone: Elements such as MRI and electrophysiology have shown promising signals in small studies, but combining imaging, wearables, and biosamples for heavy menstrual bleeding is relatively novel and not yet widely validated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18-45
* Having Periods

Exclusion Criteria:

* Currently pregnant or breastfeeding.
* Known uterine malignancy, severe anaemia requiring urgent treatment, or other acute gynaecological emergencies.
* Inability to undergo MRI (e.g., pacemaker, severe claustrophobia).
* Inability to provide informed consent.
* Current use of hormonal treatment, or use in the last 2 months

Where it's running

  • University Hospital Southampton
    Southampton, United Kingdom
    Recruiting

Study contacts

  • Principal investigator: Ying Cheong — University Hospital Southampton NHS Foundation Trust
  • Study coordinator: Ying Cheong
  • Email: y.cheong@soton.ac.uk
  • Phone: +44 7977011443

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.